Myung Hee Park

Title: Myung Hee Park: Innovator in Medical Research

Introduction

Myung Hee Park is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of medical research, particularly in the area of cell growth inhibition and vascular channel formation.

Latest Patents

Myung Hee Park holds 2 patents that focus on innovative methods for inhibiting the formation of vascular channels and cell proliferation. His first patent describes methods of inhibiting the formation of vascular channels in tissues and the proliferation of cells in non-vascularized intraepithelial neoplasia. This method involves administering a compound to the tissues or cells. His second patent provides compositions and methods for treating mammalian cells to inhibit cell growth, especially targeting proliferative cell growth associated with both malignant and non-malignant diseases. This invention includes a deoxyhypusine synthase inhibitor, typically a mono- or bisguanyl diamine or polyamine, which is administered to the cells. Additionally, diagnostic methods and kits are provided for screening patient cells to determine the effect of the deoxyhypusine synthase inhibitor on cell proliferation.

Career Highlights

Throughout his career, Myung Hee Park has worked with the United States of America as represented by the Department of Health and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has had a profound impact on medical research and treatment methodologies.

Collaborations

Myung Hee Park has collaborated with notable colleagues, including Edith C. Wolff and Judit Jakus, who have contributed to his research endeavors.

Conclusion

Myung Hee Park's innovative work in medical research has led to significant advancements in the understanding and treatment of cell growth and vascular channel formation. His contributions continue to influence the field and pave the way for future research.